Bradley, D. W. (2000). Studies of non-A, non-B hepatitis and characterization of the hepatitis C virus in chimpanzees. Curr Top Microbiol Immunol 242, 1–23. Bradley, D. W., Maynard, J. E., Popper, H., Cook, E. H., Ebert, J. W., McCaustland, K. A., Schable, C. A. & Fields, H. A. (1983). Post- transfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis 148, 254–265. Bright, H., Carroll, A. R., Watts, P. A. & Fenton, R. J. (2004). Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors. J Virol 78, 2062–2071. Bukh, J. & Apgar, C. L. (1997). Five new or recently discovered (GBV- A) virus species are indigenous to New World monkeys and may constitute a separate genus of the Flaviviridae. Virology 229, 429–436. Bukh, J., Kim, J. P., Govindarajan, S., Apgar, C. L., Foung, S. K., Wages, J., Jr, Yun, A. J., Shapiro, M. & Purcell, R. H. (1998). Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. J Infect Dis 177, 855–862. Bukh, J., Apgar, C. L. & Yanagi, M. (1999). Toward a surrogate model for hepatitis C virus: an infectious molecular clone of the GB Virus-B hepatitis agent. Virology 262, 470–478. Bukh, J., Apgar, C. L., Govindarajan, S. & Purcell, R. H. (2001a). Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J Med Virol 65, 694–697. Bukh, J., Apgar, C. L., Govindarajan, S., Emerson, S. U. & Purcell, R. H. (2001b). Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a. J Viral Hepat 8, 228–231. Bukh, J., Engle, R. E., Govindarajan, S. & Purcell, R. H. (2008). Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived. J Med Virol 80, 87–94. Cheng, Y., Zhang, W. Z., Li, J., Li, B., Zhao, J., Gao, R., Xin, S., Mao, P. & Cao, Y. (2000). Serological and histological findings in infection and transmission of GBV-C/HGV to macques. J Med Virol 60, 28–33. Choo, Q. L., Kuo, G., Weiner, A., Overby, L., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA derived from a blood- borne non-A, non-B viral hepatitis genome. Science 244, 359–362. Choo, Q.-L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, A. & other authors (1991). Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 88, 2451–2455. Deinhardt, F. & Deinhardt, J. B. (1984). Animal models. In Hepatitis A, 1st edn, pp. 185–204. Edited by R. J. Gerety. London: Academic Press. Deinhardt, F., Holmes, A. W., Capps, R. B. & Popper, H. (1967). Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med 125, 673–688. Dorrucci, M., Pezzotti, P., Phillips, A. N., Lepri, A. C. & Rezza, G. (1995). Coinfection of hepatitis C virus with human immunodefi- ciency virus and progression to AIDS. Italian Seroconversion Study. J Infect Dis 172, 1503–1508. Epstein, J. H., Quan, P. L., Briese, T., Street, C., Jabado, O., Conlan, S., Ali, K. S., Verdugo, D., Hossain, M. J. & other authors. (2010). Identification of GBV-D, a novel GB-like flavivirus from old world frugivorous bats (Pteropus giganteus) in Bangladesh. PLoS Pathog 6, e1000972. Farci, P., Alter, H. J., Govindarajan, S., Wong, D., Engle, R., Lesniewski, R. R., Mushawar, I. K., Desai, S. M., Miller, R. H. & other authors (1992a). Lack of protective immunity against reinfection with hepatitis C virus. Science 258, 135–140. http://vir.sgmjournals.org The GB viruses Farci, P., London, W. T., Wong, D. C., Dawson, G. J., Vallari, D. S., Engle, R. & Purcell, R. H. (1992b). The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second- generation assays and relationship to HCV viremia. J Infect Dis 165, 1006–1011. Farci, P., Alter, H. J., Wong, D., Miller, R. H., Govindarajan, S., Engle, R. & Shapiro, M. (1994). Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 91, 7792–7796. Feinstone, S. M. & Purcell, R. H. (1978). Non-A, non-B hepatitis. Annu Rev Med 29, 359–366. Feinstone, S. M., Kapikian, A. Z., Purcell, R., Alter, H. J. & Holland, P. V. (1975). Transfusion associated hepatitis not due to viral hepatitis A or B. N Engl J Med 292, 767–770. Fernandez-Vidal, M., Cubero, M. D., Ercilla, G., Gomara, M. J. & Haro, I. (2007). Application of a chimeric synthetic peptide in the development of a serologic method for the diagnosis of hepatitis G virus infection. Protein Pept Lett 14, 865–870. Fogeda, M., Navas, S., Martin, J., Casqueiro, M., Rodriguez, E., Arocena, C. & Carreno, V. (1999). In vitro infection of human peripheral blood mononuclear cells by GB virus C/hepatitis G virus. J Virol 73, 4052–4061. Fong, T. L., Shindo, M., Feinstone, S. M., Hoofnagle, J. & DiBisceglie, A. M. (1991). Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest 88, 1058–1060. George, S. L., Xiang, J. & Stapleton, J. T. (2003). Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 316, 191–201. George, S. L., Varmaz, D. & Stapleton, J. T. (2006). GB virus C replicates in primary T and B lymphocytes. J Infect Dis 193, 451–454. Gomara, M. J., Fernandez, L., Perez, T., Ercilla, G. & Haro, I. (2010). Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection. Anal Biochem 396, 51–58. Gorbalenya, A. E. & Koonin, E. V. (1989). Virus proteins containing the purine NTP-binding pattern. Nucleic Acids Res 17, 8413–8440. Gust, I. D. & Feinstone, S. M. (1988). Hepatitis A. Boca Raton, Florida: CRC Press, Inc. Gutierrez, R. A., Dawson, G. J., Knigge, M. F., Melvin, S. L., Heynen, C. A., Kyrk, C. R., Young, C. E., Carrick, R. J., Schlauder, G. G. & other authors (1997). Seroprevalance of GB virus C and persistence of RNA and antibody. J Med Virol 53, 167–173. Heringlake, S., Ockenga, J., Tillmann, H. L., Trautwein, C., Meissner, D., Stoll, M., Hunt, J., Jou, C., Solomon, N. & other authors (1998). GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 177, 1723–1726. Hijikata, M., Shimizu, Y. K., Kato, H., Iwamoto, A., Shih, J. W., Alter, H. J. & Purcell, R. H. (1993). Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67, 1953–1958. Hoofnagle, J. H. (1997). Hepatitis C: the clinical spectrum of disease. Hepatology 26, 15S–20S. Ishii, K., Iijima, S., Kimura, N., Lee, Y.-J., Ageyama, N., Yagi, S., Yamaguchi, K., Maki, N., Mori, K.-I. & other authors (2007). GBV-B as a pleiotropic virus: distribution of GBV-B in extrahepatic tissues in vivo. Microbes Infect 9, 515–521. Jacob, J. R., Lin, K. C., Tennant, B. C. & Mansfield, K. G. (2004). GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. J Gen Virol 85, 2525–2533. Keck, Z. Y., Sung, V. M., Perkins, S., Rowe, J., Paul, S., Liang, T. J., Lai, M. M. & Foung, S. K. (2004). Human monoclonal antibody to 243